Clincosm LogoSign in Get a demo

Safety

Showing 1 - 25 of 151
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Benefits of Different Formulations of Amphotericin B

Active, not recruiting
  • Efficacy
  • Safety
    • Jinan, Shandong, China
      Rui Yang,MD
    Nov 3, 2023

    Tumor Infiltrating Lymphocytes, Safety, Melanoma Trial in Beijing (GC101 TIL)

    Recruiting
    • Tumor Infiltrating Lymphocytes
    • +4 more
    • GC101 TIL
    • Beijing, China
      Beijing Cancer Hospital
    Nov 7, 2023

    Efficacy, Safety, Pharmacokinetics Trial in Jilin (Hepenofovir Fumarate Tablets)

    Recruiting
    • Efficacy
    • +2 more
    • Hepenofovir Fumarate Tablets
    • Jilin, Changchun, China
      The First Hospital of Jilin University
    Nov 2, 2023

    Safety, Pharmacokinetics, Pharmacodynamics Trial in Overland Park (Kratom, Placebo)

    Recruiting
    • Safety
    • +2 more
    • Overland Park, Kansas
      Altasciences Clinical Kansas, Inc.
    Oct 10, 2023

    Health, Safety, Workplace Trial (GiochiAMO a 626)

    Not yet recruiting
    • Health
    • +2 more
    • GiochiAMO a 626
    • (no location specified)
    Sep 23, 2023

    Safety, Acceptability, Usability Trial in Worldwide (Placebo Vaginal Film with Square Corners, Placebo Vaginal Film with Rounded

    Not yet recruiting
    • Safety
    • +2 more
    • Placebo Vaginal Film with Square Corners
    • Placebo Vaginal Film with Rounded Corners
    • Pittsburgh, Pennsylvania
    • +4 more
    Sep 20, 2023

    Refractory Diabetic Foot, Human Cord Blood-derived Mononuclear Cells, Efficacy Trial in Nanjing (human cord blood-derived

    Recruiting
    • Refractory Diabetic Foot
    • +4 more
    • human cord blood-derived mononuclear cells (HCB-MNCs)
    • Nanjing, China
      the First Affiliated Hospital of Nanjing Medical University
    Aug 13, 2023

    Immune Response, Safety Trial in Incheon (bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine, quadrivalent influenza

    Active, not recruiting
    • Immune Response
    • Safety
    • bivalent BNT162b2 mRNA original/omicron BA.4-5 vaccine
    • quadrivalent influenza vaccine
    • Incheon, Seo-gu, Korea, Republic of
      International St. Mary's hospital
    Jul 28, 2023

    Heart Failure, Electric Impedance, Dyspnea Trial in Córdoba (Diuretics withdrawal, Diuretics maintenance)

    Recruiting
    • Heart Failure
    • +4 more
    • Diuretics withdrawal
    • Diuretics maintenance
    • Córdoba, Córdoba (Andalucía), Spain
      Hospital Universitario Reina Sofía
    Jul 25, 2023

    Social Isolation, Well-being, Quality of Life Trial in Oslo (Offer to try Komp)

    Enrolling by invitation
    • Social Isolation
    • +10 more
    • Offer to try Komp
    • Oslo, Norway
    • +2 more
    Jun 16, 2023

    Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

    Not yet recruiting
    • Advanced Solid Tumor
    • +4 more
    • Peking, Beijing, China
      Department of radiation oncology, Peking University Third Hospit
    Jun 20, 2023

    Heart Failure, Levosimendan, Efficacy Trial in Jinan

    Recruiting
    • Heart Failure
    • +3 more
      • Jinan, Shandong, China
        First Affiliated Hospital of Shandong First Medical University (
      Jun 17, 2023

      Safety Trial in Alexandria (Intensive Care Nurses' Training Package)

      Completed
      • Safety
      • Intensive Care Nurses' Training Package
      • Alexandria, Egypt
      • +1 more
      Jun 17, 2023

      Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

      Not yet recruiting
      • Immunogenicity
      • Safety
      • Phase II:SWIM816;SARS-Cov-2;
      • +3 more
      • (no location specified)
      Jun 18, 2023

      Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

      Completed
      • Safety
      • +2 more
      • RHN-001 (one tablet 750mg)
      • RHN-001 (750mg * 2 Tablets)
      • Karachi, Sindh, Pakistan
        Center for Bioequivalence Studies and clinical research (CBSCR),
      Apr 26, 2023

      Safety and Efficacy of Distal Radial Approach

      Recruiting
      • Safety
      • Efficacy
        • Yongin, Gyeonggi-do, Korea, Republic of
          Yongcheol Kim
        Mar 8, 2023

        Bioavailability, Gut Microbiome, Safety Trial in Lubbock (Low curcumin group, High curcumin group)

        Not yet recruiting
        • Bioavailability
        • +2 more
        • Low curcumin group
        • High curcumin group
        • Lubbock, Texas
          Texas Tech University Health Sciences Center
        Mar 15, 2023

        Breast Cancer With Liposomal Doxorubicin Regimen

        Recruiting
        • Breast Cancer
        • +4 more
        • Liposomal doxorubicin containing regimen
        • Hangzhou, Zhejiang, China
          Second Affiliate Hospital of Zhejiang University
        Feb 7, 2023

        Pharmacokinetics, Safety, Tolerability Trial in Overland Park (5-methoxy-N,N-dimethyltryptamine succinate salt, Placebo)

        Recruiting
        • Pharmacokinetics
        • +2 more
        • 5-methoxy-N,N-dimethyltryptamine succinate salt
        • Placebo
        • Overland Park, Kansas
          Altasciences Clinical Kansas, Inc
        Jan 13, 2023

        Safety, Bioavailability, Pharmacokinetics Trial in Ljubljana (Linaprazan glurate)

        Completed
        • Safety
        • +2 more
        • Linaprazan glurate
        • Ljubljana, Ukmarjeva Ulica 6, Slovenia
          CRS d.o.o.
        Jan 17, 2023

        Immunogenicity, Safety, Efficacy Trial in Savannakhét (SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2.,

        Active, not recruiting
        • Immunogenicity
        • +2 more
        • SW-BIC-213;SARS-Cov-2.
        • +2 more
        • Savannakhét, Sava, Lao People's Democratic Republic
          Savannakhét Provincial hospital
        Jan 8, 2023

        Prospective G7 Dual Mobility Total Hip PMCF

        Enrolling by invitation
        • Clinical Outcomes
        • +4 more
        • G7 Dual Mobility hip
        • Jersey City, New Jersey
        • +5 more
        Jan 12, 2023

        T-lymphoblastic Lymphoma, Relapsed Disease, Refractory Lymphoma Trial in Shanghai (BCL2 Inhibitor plus IM2 regimen)

        Recruiting
        • T-lymphoblastic Lymphoma
        • +5 more
        • BCL2 Inhibitor plus IM2 regimen
        • Shanghai, Shanghai, China
          Shanghai General hospital,Shanghai Jiao Tong University School o
        Jan 10, 2023

        Safety, Adverse Event Following Immunisation, Birth Outcomes Trial in Boston, Durham, Cincinnati (Quadrivalent Recombinant

        Completed
        Has Results
        • Safety
        • +2 more
        • Quadrivalent Recombinant Influenza Vaccine
        • Quadrivalent Inactivated Influenza Vaccine
        • Boston, Massachusetts
        • +2 more
        Jan 9, 2023

        Nalbuphine Allergy, Ablation, Safety Trial in China (Nalbuphine, Morphine)

        Recruiting
        • Nalbuphine Allergy
        • +2 more
        • Hefei, Anhui, China
        • +19 more
        Dec 28, 2022